February 22, 2022
Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.
- Creates late-stage, diversified pipeline that uses a multi-targeted approach to reset dysregulated biology to address considerable unmet needs
- Combined pipeline extends from pre-clinical to registration studies, with near-term clinical and regulatory milestones
- Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end